Dr. Jessicca Rege is current the CEO of Sus Clinicals a biotech company that specializes in developing large animal pig based preclinical models which have the ability to accelerate development of life-saving cancer therapeutics. Dr. Rege also serves as the Chief Medical Officer of Oncoscope- AI, a company that is utilizing AI to build up to date peer reviewed evidence from intervention studies to help aid in medical decisions for patients.
Pharmaceutical executive with extensive experience in Research and Development and Global Medical affairs from pre-IND to Phase IV/compound commercialization of small molecules, cytotoxics and biologics in oncology, has been leading oncology organizations for the past 20 years.
CRDWC 2025
Keynote Presentation